• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA修饰调节因子在多囊卵巢综合征中作用的生物信息学分析

Bioinformatics analysis of the role of RNA modification regulators in polycystic ovary syndrome.

作者信息

Quan Kewei, Ning Shuting, You Zilin, Deng Gaopi

机构信息

Department of Obstetrics and Gynecology, Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, 523000, China.

The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

出版信息

Heliyon. 2024 Aug 23;10(17):e36706. doi: 10.1016/j.heliyon.2024.e36706. eCollection 2024 Sep 15.

DOI:10.1016/j.heliyon.2024.e36706
PMID:39281527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11400967/
Abstract

PURPOSE

Polycystic ovary syndrome (PCOS) is the most common metabolic and endocrine disorder affecting women of reproductive age. The pathogenesis of PCOS is influenced by factors such as race, genetics, environment, hyperandrogenemia, hyperinsulinemia, and obesity. However, the molecular mechanisms linking RNA modification and PCOS remain underexplored. This study aims to investigate the potential genetic and molecular pathways connecting RNA modification with PCOS through bioinformatics analyses.

METHODS

The GSE34526, GSE5850, and GSE98421 datasets were obtained from the National Center for Biotechnology Information Gene Expression Omnibus database. We identified intersecting differentially expressed genes (DEGs) and RNA modification-related genes within the GSE34526 dataset and visualized the overlaps using a Venn diagram. Subsequent analyses included Gene Ontology (GO), pathway enrichment (Kyoto Encyclopedia of Genes and Genomes), gene set enrichment analysis (GSEA), gene set variation analysis (GSVA), and immune infiltration analysis. Additionally, we constructed a protein-protein interaction network as well as mRNA-miRNA, mRNA-RNA binding protein, and mRNA-transcription factor (TF) regulatory networks. The expression and receiver operating characteristic curves of hub genes were also identified.

RESULTS

The expression of several RNA modification-related DEGs (RMRDEGs) (, , , , and ) showed significant differences in PCOS patients. GSEA and GSVA indicated that RMRDEGs were enriched in the hedgehog, MAPK, JAK STAT, and Notch pathways. Key transcription factors, including SP7, KLF8, HCFC1, IRF1, and MLLT1, were identified in the TF regulatory networks.

CONCLUSIONS

These findings suggest that there are gene and miRNA profile alterations exist in PCOS patients and highlight immune-related differences. This knowledge could pave the way for new research directions in the diagnosis and treatment of PCOS.

摘要

目的

多囊卵巢综合征(PCOS)是影响育龄女性的最常见的代谢和内分泌紊乱疾病。PCOS的发病机制受种族、遗传、环境、高雄激素血症、高胰岛素血症和肥胖等因素影响。然而,RNA修饰与PCOS之间的分子机制仍未得到充分探索。本研究旨在通过生物信息学分析探讨将RNA修饰与PCOS联系起来的潜在遗传和分子途径。

方法

从美国国立生物技术信息中心基因表达综合数据库中获取GSE34526、GSE5850和GSE98421数据集。我们在GSE34526数据集中鉴定出相交的差异表达基因(DEGs)和RNA修饰相关基因,并使用维恩图可视化重叠情况。后续分析包括基因本体论(GO)、通路富集(京都基因与基因组百科全书)、基因集富集分析(GSEA)、基因集变异分析(GSVA)和免疫浸润分析。此外,我们构建了蛋白质-蛋白质相互作用网络以及mRNA- miRNA、mRNA-RNA结合蛋白和mRNA-转录因子(TF)调控网络。还鉴定了枢纽基因的表达和受试者工作特征曲线。

结果

几个RNA修饰相关的差异表达基因(RMRDEGs)(、、、和)在PCOS患者中的表达存在显著差异。GSEA和GSVA表明RMRDEGs在刺猬、丝裂原活化蛋白激酶(MAPK)、Janus激酶信号转导和转录激活因子(JAK STAT)以及Notch通路中富集。在TF调控网络中鉴定出关键转录因子,包括SP7、KLF8、HCFC1、IRF1和MLLT1。

结论

这些发现表明PCOS患者存在基因和miRNA谱改变,并突出了免疫相关差异。这些知识可为PCOS的诊断和治疗开辟新的研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/c43b122d7cb9/mmcfigs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/a613f0adf147/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/508803c03836/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/955af00becae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/ba59ba755b70/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/f774a7134dde/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/2ddbb069549a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/dc47410c97eb/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/65e90e7df475/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/d6546eb9e157/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/c43b122d7cb9/mmcfigs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/a613f0adf147/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/508803c03836/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/955af00becae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/ba59ba755b70/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/f774a7134dde/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/2ddbb069549a/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/dc47410c97eb/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/65e90e7df475/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/d6546eb9e157/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a176/11400967/c43b122d7cb9/mmcfigs2.jpg

相似文献

1
Bioinformatics analysis of the role of RNA modification regulators in polycystic ovary syndrome.RNA修饰调节因子在多囊卵巢综合征中作用的生物信息学分析
Heliyon. 2024 Aug 23;10(17):e36706. doi: 10.1016/j.heliyon.2024.e36706. eCollection 2024 Sep 15.
2
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.通过通路富集分析和枢纽基因- microRNA网络揭示多囊卵巢综合征(PCOS)的关键生物标志物和治疗药物
Iran J Pharm Res. 2023 Nov 20;22(1):e139985. doi: 10.5812/ijpr-139985. eCollection 2023 Jan-Dec.
3
Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.基于生物信息学分析鉴定 2 型糖尿病与多囊卵巢综合征的关键基因及分子通路
Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3255-3269. doi: 10.26355/eurrev_202304_32097.
4
Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome.与非酒精性脂肪性肝病和多囊卵巢综合征相关的关键基因
Front Mol Biosci. 2022 May 25;9:888194. doi: 10.3389/fmolb.2022.888194. eCollection 2022.
5
Construction of a ceRNA network in polycystic ovary syndrome (PCOS) driven by exosomal lncRNA.由外泌体长链非编码RNA驱动的多囊卵巢综合征(PCOS)中ceRNA网络的构建
Front Genet. 2022 Nov 4;13:979924. doi: 10.3389/fgene.2022.979924. eCollection 2022.
6
Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.多囊卵巢综合征:自噬相关 mRNA-miRNA-lncRNA 网络中新型和枢纽生物标志物的鉴定。
Front Endocrinol (Lausanne). 2022 Nov 29;13:1032064. doi: 10.3389/fendo.2022.1032064. eCollection 2022.
7
Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.构建竞争性内源性RNA网络以鉴定多囊卵巢综合征的药物靶点
Hum Reprod. 2022 Nov 24;37(12):2856-2866. doi: 10.1093/humrep/deac218.
8
Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.通过整合生物信息学分析和小分子治疗药物预测鉴定多囊卵巢综合征的关键途径和基因。
Reprod Biol Endocrinol. 2021 Feb 23;19(1):31. doi: 10.1186/s12958-021-00706-3.
9
Exploring the molecular targets and mechanism of in treating polycystic ovary syndrome based on network pharmacology.基于网络药理学探索[具体药物名称未给出]治疗多囊卵巢综合征的分子靶点及机制。
Ann Transl Med. 2023 Feb 15;11(3):149. doi: 10.21037/atm-23-29.
10
Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.基于生物信息学分析鉴别高雄激素与正常雄激素多囊卵巢综合征的枢纽基因和生物标志物。
Comb Chem High Throughput Screen. 2023;26(1):126-134. doi: 10.2174/1386207325666220404101009.

引用本文的文献

1
Identification and validation of biomarkers associated with glycolysis in polycystic ovarian syndrome.多囊卵巢综合征中与糖酵解相关的生物标志物的鉴定与验证
Sci Rep. 2025 Jul 26;15(1):27199. doi: 10.1038/s41598-025-11591-w.

本文引用的文献

1
The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway.苍附导痰汤对啮齿动物模型多囊卵巢综合征的改善作用与m6A甲基化和Wnt/β-连环蛋白通路有关。
Gynecol Endocrinol. 2023 Dec;39(1):2181637. doi: 10.1080/09513590.2023.2181637. Epub 2023 Feb 23.
2
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8 T cells.YTHDF2 通过 CD8 T 细胞协调肿瘤相关巨噬细胞重编程并控制抗肿瘤免疫。
Nat Immunol. 2023 Feb;24(2):255-266. doi: 10.1038/s41590-022-01398-6. Epub 2023 Jan 19.
3
Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
基于 RNA 修饰调控基因的卵巢癌亚型:一种新的预后预测模型。
Front Endocrinol (Lausanne). 2022 Dec 5;13:972341. doi: 10.3389/fendo.2022.972341. eCollection 2022.
4
Notch Signaling Induced by Endoplasmic Reticulum Stress Regulates Cumulus-Oocyte Complex Expansion in Polycystic Ovary Syndrome.内质网应激诱导的 Notch 信号通路调控多囊卵巢综合征中卵丘-卵母细胞复合物的扩展。
Biomolecules. 2022 Jul 27;12(8):1037. doi: 10.3390/biom12081037.
5
Identifies microtubule-binding protein as a novel cancer biomarker associated with ferroptosis and tumor microenvironment.鉴定微管结合蛋白为一种与铁死亡和肿瘤微环境相关的新型癌症生物标志物。
Comput Struct Biotechnol J. 2022 Jun 24;20:3322-3335. doi: 10.1016/j.csbj.2022.06.046. eCollection 2022.
6
The Role of mA on Female Reproduction and Fertility: From Gonad Development to Ovarian Aging.毫安对女性生殖与生育的作用:从性腺发育到卵巢衰老
Front Cell Dev Biol. 2022 May 30;10:884295. doi: 10.3389/fcell.2022.884295. eCollection 2022.
7
Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma.肺腺癌中m1A调控因子的功能、免疫特征及临床意义的综合分析
Front Oncol. 2022 May 30;12:882292. doi: 10.3389/fonc.2022.882292. eCollection 2022.
8
Evidence for TET-mediated DNA demethylation as an epigenetic alteration in cumulus granulosa cells of women with polycystic ovary syndrome.证据表明,TET 介导的 DNA 去甲基化是多囊卵巢综合征患者卵丘颗粒细胞中的一种表观遗传改变。
Mol Hum Reprod. 2022 Jun 30;28(7). doi: 10.1093/molehr/gaac019.
9
N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through Modulating Macrophage Polarization.N1-甲基腺苷(m1A)通过调节巨噬细胞极化与腹主动脉瘤发病机制相关。
Front Cardiovasc Med. 2022 May 10;9:883155. doi: 10.3389/fcvm.2022.883155. eCollection 2022.
10
A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.一种与免疫微环境相关的新型 m1A 评分模型预测肝细胞癌的预后。
Front Immunol. 2022 Mar 24;13:805967. doi: 10.3389/fimmu.2022.805967. eCollection 2022.